NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
6.21
+0.01 (0.16%)
At close: Aug 15, 2025, 4:00 PM
6.29
+0.08 (1.29%)
After-hours: Aug 15, 2025, 6:17 PM EDT

Company Description

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.

It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains.

In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients’ oncology programs covering discovery and commercialization.

NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

NeoGenomics, Inc.
NeoGenomics logo
CountryUnited States
Founded2001
IPO DateNov 2, 1999
IndustryDiagnostics & Research
SectorHealthcare
Employees2,200
CEOAnthony Zook

Contact Details

Address:
9490 NeoGenomics Way
Fort Myers, Florida 33912
United States
Phone239 768 0600
Websiteneogenomics.com

Stock Details

Ticker SymbolNEO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001077183
CUSIP Number64049M209
ISIN NumberUS64049M2098
Employer ID74-2897368
SIC Code8734

Key Executives

NamePosition
Anthony P. ZookChief Executive Officer and Director
Warren StonePresident and Chief Operating Officer
Jeffrey S. Sherman M.B.A.Chief Financial Officer
Alicia C. OlivoExecutive Vice President of Business Development, General Counsel and Corporate Secretary
Gregory D. AunanSenior Vice President and Chief Accounting Officer
Kendra SweeneyVice President of Investor Relations and Communications
Hutan Hashemi J.D.Chief Compliance Officer
Gary PassmanChief People and Culture Officer
Beth EastlandExecutive Vice President of Enterprise Sales

Latest SEC Filings

DateTypeTitle
Aug 14, 2025SCHEDULE 13GFiling
Aug 13, 2025SCHEDULE 13GFiling
Aug 8, 20258-KCurrent Report
Jul 29, 202510-QQuarterly Report
Jul 29, 20258-KCurrent Report
Jul 17, 2025SCHEDULE 13G/AFiling
Jun 24, 20258-KCurrent Report
Jun 16, 2025S-8Securities to be offered to employees in employee benefit plans
May 27, 20258-KCurrent Report
May 14, 2025SCHEDULE 13G/AFiling